PNRR CN_00000041 / CN5 – National Center for the development of gene therapy and drugs with RNA technology (RNA Drug development)
National Centers
Intervention proposals for the strengthening of research structures and the creation of “national champions” of R&D on some Key Enabling Technologies to be financed within the scope of the National Recovery and Resilience Plan, Mission 4 Component 2 Investment 1.4 “Strengthening of research and creation structures of “national R&D champions” on some Key Enabling Technologies” funded by the European Union – NextGenerationEU.
CN_00000041 / CN5 – National Center for the development of gene therapy and drugs with RNA technology (RNA Drug development)
The National Center for the development of gene therapy and drugs with RNA technology carries out research in areas of strategic importance for the country for the production of therapies or the design of procedures for human health, integrating the development of therapies with the their targeted administration (precision delivery). It aims to create and renovate research infrastructures and laboratories, create and develop research programs and activities to encourage the birth and growth of entrepreneurial initiatives with a higher technological content (innovative start-ups and research spin-offs), and aimed at valorising the results of research in the specified areas. The Center focuses its activities in areas of high innovative value such as gene therapy applied to the treatment of cancer or hereditary diseases and RNA-based technologies, integrating advanced biocomputing skills and intelligent nanomaterials.
Website: https://www.unipd.it/fondazione-centro-nazionale-terapia-genica
Proposing body: University of Padua.
HUB: National Research Center Foundation “Development of gene therapy and drugs with RNA technology”.
SPOKE of ICCOM affiliation: SPOKE 7 – Biocomputing.
ICCOM Principal Investigator for the Project: Silvia Rinaldi.
Duration: 01/11/2022 – 31/10/2025.
Overall project cost: € 328,814,550.46.
ICCOM total cost: € 106,278.00.
CUP: B83C22002860006.
For further information: scheda MUR
